Phenytoin-induced reduction of voriconazole serum concentration is not compensated by doubling the dosage

Por Alffenaar, Jan-Willem C, van der Elst, Kim C M, Uges, Donald R A, Kosterink, Jos G W, Daenen, Simon M G J
Publicado em 2009

Therapeutic Drug Monitoring of Posaconazole: an Update

Por Dekkers, Bart G. J., Bakker, Martijn, van der Elst, Kim C. M., Sturkenboom, Marieke G. G., Veringa, Anette, Span, Lambert F. R., Alffenaar, Jan-Willem C.
Publicado no Curr Fungal Infect Rep (2016)

Clinical Validation of the Analysis of Fluconazole in Oral Fluid in Hospitalized Children

Por van der Elst, Kim C. M., van Alst, Manouche, Lub-de Hooge, Marjolijn N., van Hateren, Kai, Kosterink, Jos G. W., Alffenaar, Jan-Willem C., Schölvinck, Elisabeth H.
Publicado no Antimicrob Agents Chemother (2014)

Dried Blood Spot Analysis Suitable for Therapeutic Drug Monitoring of Voriconazole, Fluconazole, and Posaconazole

Por van der Elst, Kim C. M., Span, Lambert F. R., van Hateren, Kai, Vermeulen, Karin M., van der Werf, Tjip S., Greijdanus, Ben, Kosterink, Jos G. W., Uges, Donald R. A., Alffenaar, Jan-Willem C.
Publicado em 2013

Low Caspofungin Exposure in Patients in Intensive Care Units

Por van der Elst, Kim C. M., Veringa, Anette, Zijlstra, Jan G., Beishuizen, Albertus, Klont, Rob, Brummelhuis-Visser, Petra, Uges, Donald R. A., Touw, Daan J., Kosterink, Jos G. W., van der Werf, Tjip S., Alffenaar, Jan-Willem C.
Publicado no Antimicrob Agents Chemother (2017)